Journal of Viral Hepatitis

Editorial
pp. 1-1(1)
Authors: Foster, G.; Karayiannis, P.; Lok, A.; Thomas, H.

Old and emerging therapies in chronic hepatitis C: an update
pp. 2-11(10)
Authors: Deutsch, M.; Hadziyannis, S.J.

Underestimation of chronic hepatitis B virus infection in the United States of America
pp. 12-13(2)
Authors: Cohen, C.; Evans, A. A.; London, W. T.; Block, J.; Conti, M.; Block, T.

Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme
pp. 14-19(6)
Authors: Su, F.-H.; Chen, J.-D.; Cheng, S.-H.; Sung, K.-Y.; Jeng, J.-J.; Chu, F.-Y.

Long-term lamivudine treatment of children with chronic hepatitis B: durability of therapeutic responses and safety
pp. 20-27(8)
Authors: Jonas, M. M.; Little, N. R.; Gardner, S. D.

Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithm
pp. 28-36(9)
Authors: Yood, M. Ulcickas; Quesenberry, C. P.; Guo, D.; Wells, K.; Shan, J.; Sanders, L.; Skovron, M. L.; Iloeje, U.; Caldwell, C.; Manos, M. M.

Exacerbation of chronic hepatitis B infection after delivery
pp. 37-41(5)
Authors: ter Borg, M. J.; Leemans, W. F.; de Man, R. A.; Janssen, H. L. A.

Symptomatology and health attitudes of chronic hepatitis B patients in the USA
pp. 42-51(10)
Authors: Hann, H.-W.; Han, S.-H.; Block, T. M.; Harris, M.; Maa, J.-F.; Fisher, R. T.; Atillasoy, E.

Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3
pp. 52-57(6)
Authors: Powis, J.; Peltekian, K. M.; Lee, S. S.; Sherman, M.; Bain, V. G.; Cooper, C.; Krajden, M.; Deschenes, M.; Balshaw, R. F.; Heathcote, E. Jenny; Yoshida, E. M.

Association of amino acid variations in the NS5A and E2-PePHD region of hepatitis C virus 1b with hepatocellular carcinoma
pp. 58-65(8)
Authors: Hung, C.-H.; Chen, C.-H.; Lee, C.-M.; Wu, C.-M.; Hu, T.-H.; Wang, J.-H.; Yen, Y.-H.; Lu, S.-N.

Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of the transcription-mediated amplification assay
pp. 66-70(5)
Authors: Ferraro, D.; Giglio, M.; Bonura, C.; Di Marco, V.; Mondelli, M. U.; Craxì, A.; Di Stefano, R.

Association of TLR7 single nucleotide polymorphisms with chronic HCV-infection and response to interferon-a-based therapy
pp. 71-78(8)
Authors: Schott, E.; Witt, H.; Neumann, K.; Bergk, A.; Halangk, J.; Weich, V.; Müller, T.; Puhl, G.; Wiedenmann, B.; Berg, T.